| Dr James M Pawlus, MD | |
|
1441 Ridge St, Naples, FL 34103-4211 | |
| (239) 643-1155 | |
| (239) 643-9816 |
| Full Name | Dr James M Pawlus |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 1441 Ridge St, Naples, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447242946 | NPI | - | NPPES |
| 058937300 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | ME61116 (Florida) | Primary |
| Entity Name | Radiology Associates Of South Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699759183 PECOS PAC ID: 5799689659 Enrollment ID: O20031121000573 |
News Archive
This position paper recommends a set of standards for quality assessment of continuing professional development (CPD) for medicines research and development (R&D).
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc across the globe, with more than 14.89 million people infected. Coronavirus disease (COVID-19), caused by SARS-CoV-2, has a string of symptoms that include cough, fever, and difficulty of breathing. As the disease evolved, many patients reported the loss of smell and taste as other accompanying symptoms.
XBiotech Inc. announced today the publication of findings that point toward a white blood cell-derived interleukin-1 alpha (IL-1⍺) as a cause of blood clots that could lead to heart attacks or strokes.
› Verified 2 days ago
| Entity Name | Naples Radiologists, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164414991 PECOS PAC ID: 5395631162 Enrollment ID: O20040227000010 |
News Archive
This position paper recommends a set of standards for quality assessment of continuing professional development (CPD) for medicines research and development (R&D).
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc across the globe, with more than 14.89 million people infected. Coronavirus disease (COVID-19), caused by SARS-CoV-2, has a string of symptoms that include cough, fever, and difficulty of breathing. As the disease evolved, many patients reported the loss of smell and taste as other accompanying symptoms.
XBiotech Inc. announced today the publication of findings that point toward a white blood cell-derived interleukin-1 alpha (IL-1⍺) as a cause of blood clots that could lead to heart attacks or strokes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James M Pawlus, MD Po Box 1187, Indianapolis, IN 46206-1187 Ph: (888) 656-6020 | Dr James M Pawlus, MD 1441 Ridge St, Naples, FL 34103-4211 Ph: (239) 643-1155 |
News Archive
This position paper recommends a set of standards for quality assessment of continuing professional development (CPD) for medicines research and development (R&D).
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc across the globe, with more than 14.89 million people infected. Coronavirus disease (COVID-19), caused by SARS-CoV-2, has a string of symptoms that include cough, fever, and difficulty of breathing. As the disease evolved, many patients reported the loss of smell and taste as other accompanying symptoms.
XBiotech Inc. announced today the publication of findings that point toward a white blood cell-derived interleukin-1 alpha (IL-1⍺) as a cause of blood clots that could lead to heart attacks or strokes.
› Verified 2 days ago
William J Ford Iii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4301 Gulf Shore Blvd N Apt 1002, Naples, FL 34103 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Daniel Singer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1441 Ridge St, Naples, FL 34103 Phone: 239-643-1155 Fax: 239-643-9816 | |
William C Doebler, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6101 Pine Ridge Rd, Naples, FL 34119 Phone: 239-348-4000 Fax: 239-348-4439 | |
Dr. Jan Malat, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 877 111th Ave N, Suite 1, Naples, FL 34108 Phone: 239-594-8002 Fax: 239-594-3447 | |
Frank A Reda Iii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9950 Boca Cir, Naples, FL 34109 Phone: 239-592-6828 | |
Dr. Matthew G Strange, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1441 Ridge St, Naples, FL 34103 Phone: 239-643-1155 Fax: 239-643-9816 | |
Dr. Pamela L Caslowitz, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1441 Ridge St, Naples, FL 34103 Phone: 239-643-1155 Fax: 239-643-9816 |